glp 1 receptor agonists for type 2 diabetes GLP-1 in the treatment of – state-of-the-art PDB-101: Molecule of the Month:
Description
Tang ST, Tang HQ, Su H, et al
Buteau J, El-Assaad W, Rhodes CJ, Rosenberg L, Joly E, Prentki M
Abstract Childhood obesity is a global health crisis with limited effective therapies beyond lifestyle modification
Members lose 29% more weight with Med+ At 12 months, Med+ members prescribed a GLP-1 medication who engaged regularly with the GLP-1 Success Program lost 29.1% more body weight , on average, than those who did not engage in behavioral support*
